Showing results (31-40 of 56) with videos related to

Sort By:
Pageof 6
Breast Cancer Research : BCR|January 10, 2024
Machine learning prediction of pathological complete response and overall survival of breast cancer patients in an underserved inner-city populationKevin Dell'Aquila, Abhinav Vadlamani, Takouhie Maldjian, et al.
The Journal of Pathology|September 29, 2011
Hsa-miR-375 is differentially expressed during breast lobular neoplasia and promotes loss of mammary acinar polarityOrsi Giricz, Paul A Reynolds, Andrew Ramnauth, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 1, 2015
Expression, Clinical Significance, and Receptor Identification of the Newest B7 Family Member HHLA2 ProteinMurali Janakiram, Jordan M Chinai, Susan Fineberg, et al.
Cancer Research|October 18, 2017
An Akt3 Splice Variant Lacking the Serine 472 Phosphorylation Site Promotes Apoptosis and Suppresses Mammary TumorigenesisKimita Suyama, Jiahong Yao, Huizhi Liang, et al.
Cancer Research|June 17, 2021
An AIB1 Isoform Alters Enhancer Access and Enables Progression of Early-Stage Triple-Negative Breast CancerGhada M Sharif, Moray J Campbell, Apsra Nasir, et al.
Biorxiv : the Preprint Server for Biology|September 5, 2025
Quiescent OXPHOS-high triple-negative breast cancer cells that persist after chemotherapy depend on BCL-XL for survivalSlawomir Andrzejewski, Marie Winter, Leandro Encarnacao Garcia, et al.
Neuro-Oncology|May 24, 2022
A comprehensive profiling of the immune microenvironment of breast cancer brain metastasesGaia Griguolo, Anna Tosi, Maria Vittoria Dieci, et al.
Breast Cancer Research and Treatment|September 27, 2013
Phase I-II study of the farnesyl transferase inhibitor tipifarnib plus sequential weekly paclitaxel and doxorubicin-cyclophosphamide in HER2/neu-negative inflammatory carcinoma and non-inflammatory estrogen receptor-positive breast carcinomaEleni Andreopoulou, Ivette S Vigoda, Vicente Valero, et al.
Breast Cancer Research and Treatment|June 7, 2014
A phase I-II study of the histone deacetylase inhibitor vorinostat plus sequential weekly paclitaxel and doxorubicin-cyclophosphamide in locally advanced breast cancerYifan Tu, Dawn L Hershman, Kapil Bhalla, et al.
Archives of Pathology & Laboratory Medicine|March 10, 2022
Concordance in Breast Cancer Grading by Artificial Intelligence on Whole Slide Images Compares With a Multi-Institutional Cohort of Breast PathologistsSiddhartha Mantrala, Paula S Ginter, Aditya Mitkari, et al.
Pageof 6